The GRADE trial suggested no difference in cognitive decline across insulin glargine, the DPP4 inhibitor sitagliptin, the sulfonylurea glimepiride, and the GLP1 receptor agonist liraglutide, but the mean age was 57.1 years, and SGLT2 inhibitors were not examined [54]
Liensinine alleviates high fat diet (HFD)-Induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling
* Correspondence: Wei Zhang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
No, it is not necessary to take both
The objective of Lee et al
IFX, a recombinant humanized monoclonal antibody against TNF-, is now approved for use in several immune-mediated disorders, including psoriasis, RA, IBD, ankylosing spondylitis, and IVIG resistant KD ( A coronavirus and IBD reporting database on Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) has shown a cluster of outcomes for IBD patients diagnosed with COVID-19
